Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2400173	甘精胰岛素利司那肽注射液（Ⅰ）	insulin glargine;lixisenatide	Injection	Biological Products	Supplementary Application	2024-08-09		Sanofi KK;Sanofi-Aventis Deutschland GmbH			view
JYSB2400099	甘精胰岛素利司那肽注射液（Ⅰ）	insulin glargine;lixisenatide	Injection	Biological Products	Supplementary Application	2024-05-06		Sanofi KK;Sanofi-Aventis Deutschland GmbH			view